← Back to search
THE EMMES COMPANY, LLC
ROCKVILLE, MD, 20850
Unclaimed
Prime contracting experience
Showing the 50 most recent of 106 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Health and Human Services National Institutes of Health | LOGISTICAL AND IT SUPPORT FOR THE NCI CENTRAL INDIVIDUAL REVIEW BOARD (CIRB) | — | $27,417,478 | Sep 30, 2026 | Sep 1, 2024 – Aug 31, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | NIDA DATA, STATISTICS, AND CLINICAL TRIAL SUPPORT CENTER MANAGEMENT AND SUPPORT. 07/01/2021 - 10/30/2023. N01DA-19-2250. TASK ORDER 75N95021F00003 (TO22). | 75N95019D00013USAspending | $1,149,960 | Sep 24, 2026 | Jul 1, 2021 – Feb 28, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | LONGITUDINAL FOLLOW-UP OF INDIVIDUALS WITH OPIOID USE DISORDER (LFU-OUD). 09/01/2021 - 08/31/2026. N01DA-19-2250. TASK ORDER 75N95021F00007 (TO26). | 75N95019D00013USAspending | $1,822,096 | Sep 21, 2026 | Sep 1, 2021 – Aug 31, 2026 |
| Prime | Department of Health and Human Services National Institutes of Health | NICHD:R&D:DATA COORDINATING CENTER FOR THE FOLLOW-UP OF THE SECOND PHASE (COHORT 2) OF THE PRENATAL AND CHILDHOOD MECHANISMS OF HEALTH DISPARITIES OBSERVATIONAL STUDY:NON-SEVERABLE | 75N94018D00006USAspending | $1,387,469 | Sep 16, 2026 | Aug 15, 2025 – Oct 31, 2028 |
| Prime | Department of Health and Human Services National Institutes of Health | NINDS CENTER FOR CLINICAL TRIAL RESOURCES | — | $9,122,780 | Sep 10, 2026 | Sep 30, 2022 – Sep 29, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT | — | $66,032,644 | Sep 2, 2026 | Jul 28, 2017 – May 28, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | CLINICAL TRIALS AND INFORMATION MANAGEMENT SUPPORT | — | $51,133,673 | Sep 1, 2026 | Jun 1, 2021 – May 31, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | DATA MANAGEMENT AND DATA WAREHOUSING | — | $14,186,615 | Aug 26, 2026 | Oct 15, 2019 – Oct 14, 2026 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF - STATISTICAL AND DATA COORDINATING CENTER FOR CLINICAL RESEARCH IN INFECTIOUS DISEASES(SDCC) | — | $100,150,458 | Aug 20, 2026 | Feb 27, 2015 – Feb 28, 2021 |
| Prime | Department of Health and Human Services National Institutes of Health | OPTIMIZING RETENTION, DURATION AND DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). AUGUST 15, 2024 TO MARCH 31, 2028. N01DA-22-2253. TASK ORDER NO. 75N95024F00007 (TO23). | 75N95022D00017USAspending | $1,860,579 | Aug 19, 2026 | Aug 15, 2024 – Mar 31, 2028 |
| Prime | Department of Health and Human Services National Institutes of Health | DATA AND STATISTICAL ANALYSIS FOR GLP-1 AS AN ADJUNCT TO BUPRENORPHINE. MAY 21, 2025 - FEBRUARY 29, 2028. N01DA-22-2253. TASK ORDER NO. 75N95025F00002 (TO26). | 75N95022D00017USAspending | $1,747,575 | Aug 7, 2026 | May 21, 2025 – Feb 29, 2028 |
| Prime | Department of Health and Human Services National Institutes of Health | DSC MANAGEMENT AND SUPPORT. APRIL 29, 2026 THROUGH FEBRUARY 28, 2027. N01DA-22-2253. TASK ORDER NO. 75N98026F00002 (TO 28) | 75N95022D00017USAspending | $2,359,700 | Aug 6, 2026 | Apr 29, 2026 – Feb 28, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | DATA COORDINATING CENTER TO PROVIDE SERVICES TO WORK COLLABORATIVELY WITH THE NATIONAL NEUROHIV TISSUE CONSORTIUM CLINICAL SITES TO PROVIDE MANAGEMENT AND DATABASE CAPABILITIES, SCIENTIFIC EXPERTISE, AND EXPANSION CAPABILITY TO COORDINATE THE DISTRIB | — | $13,535,405 | Aug 5, 2026 | Aug 7, 2023 – Aug 6, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | STATISTICAL AND DATA COORDINATING CENTER FOR CLINICAL RESEARCH IN INFECTIOUS DISEASES (SDCC) | — | $176,560,287 | Aug 5, 2026 | Mar 1, 2021 – Feb 28, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF OTHER FUNCTION NINDS CENTER FOR CLINICAL RESEARCH RESOURCES | — | $6,970,620 | Aug 5, 2026 | Sep 19, 2017 – Sep 29, 2022 |
| Prime | Department of Health and Human Services National Institutes of Health | NIDA DATA, STATISTICS, AND CLINICAL TRIAL SUPPORT CENTER MANAGEMENT AND SUPPORT. 07/01/2021 - 6/14/2024. N01DA-19-2250. TASK ORDER 75N95021F00004 (TO23). | 75N95019D00013USAspending | $1,337,939 | Aug 5, 2026 | Jul 1, 2021 – Sep 30, 2024 |
| Prime | Department of Health and Human Services National Institutes of Health | NIDA DATA, STATISTICS, AND CLINICAL TRIAL SUPPORT CENTER MANAGEMENT AND SUPPORT. 03/01/2021 - 02/28/2022. N01DA-19-2250. TASK ORDER 75N95021F00001 (TO20). | 75N95019D00013USAspending | $1,087,752 | Jul 31, 2026 | Mar 1, 2021 – Feb 28, 2022 |
| Prime | Department of Health and Human Services National Institutes of Health | DSC MANAGEMENT AND SUPPORT FOR HELPING TO END ADDICTION LONG-TERM INITIATIVE (HEAL). 9/21/2020-9/20/2021. N01DA-19-2250. TASK ORDER 75N95020F00008 (TO19). | 75N95019D00013USAspending | $1,285,018 | Jul 31, 2026 | Sep 21, 2020 – Sep 20, 2021 |
| Prime | Department of Health and Human Services National Institutes of Health | DSC MANAGEMENT AND SUPPORT FOR HELPING TO END ADDICTION LONG-TERM INITIATIVE (HEAL). 9/1/2021-8/31/2022. N01DA-19-2250. TASK ORDER 75N95021F00005 (TO24). | 75N95019D00013USAspending | $2,419,237 | Jul 31, 2026 | Sep 1, 2021 – Aug 31, 2022 |
| Prime | Department of Health and Human Services National Institutes of Health | TO5. CLINICAL COORDINATING CENTER FOR NIDA'S CLINICAL TRIALS NETWORK. CONTRACT TYPE: IDIQ TASK ORDER. POP: 8/15/24 - 8/14/29 | 75N95024D00037USAspending | $2,501,452 | Jul 30, 2026 | Jul 16, 2025 – Mar 31, 2028 |
| Prime | Department of Health and Human Services National Institutes of Health | BETTER TOGETHER: INTEGRATING MOUD IN AFRICAN AMERICAN COMMUNITY SETTINGS. SEPTEMBER 15, 2023 TO JANUARY 31, 2026. N01DA-22-2253. TASK ORDER 75N95023F00004 (TO8). | 75N95022D00017USAspending | $999,995 | Jul 29, 2026 | Sep 15, 2023 – Jan 31, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | TASK ORDER 6 FOR THE CTN CLINICAL RESEARCH COORDINATING CENTER (CCC) CONTRACT | 75N95024D00037USAspending | $4,960,819 | Jul 7, 2026 | Aug 15, 2024 – Aug 14, 2029 |
| Prime | Department of Health and Human Services National Institutes of Health | CTN'S CLINICAL COORDINATING CENTER CONTRACT. CTN STUDY, OPTIMIZING RETENTION, DURATION AND DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). POP: 8/15/24 - 4/2/28 | 75N95024D00037USAspending | $3,944,274 | Jun 29, 2026 | Aug 15, 2024 – Apr 2, 2028 |
| Prime | Department of Health and Human Services National Institutes of Health | KETAMINE FOR METHAMPHETAMINE USE DISORDER STUDY (CTN-0132). 09/28/2022 - 08/21/2025. DSC6. 75N95022F00004 (TO4). | 75N95022D00017USAspending | $2,075,621 | Jun 25, 2026 | Sep 28, 2022 – Mar 31, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | TO PROVIDE BIO-MEDICAL AND BEHAVIORAL RESEARCH RESOURCES AND CLINICAL RESEARCH COORDINATING SERVICES TO SUPPORT THE NIDA CLINICAL TRIALS NETWORK (CTN) HEAL STUDIES. | 75N95020D00012USAspending | $5,120,312 | Jun 17, 2026 | Apr 21, 2021 – Apr 20, 2022 |
| Prime | Department of Health and Human Services National Institutes of Health | STANDARD AND HIGH DOSE ED BUPRENORPHINE INDUCTION. 09/15/2023 - 05/31/2026. N01DA-22-2253. TASK ORDER 75N95023F00005 (TO9). | 75N95022D00017USAspending | $1,249,376 | May 29, 2026 | Sep 15, 2023 – Jan 31, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | CLINICAL RESEARCH SUPPORT AND COLLABORATION FOR NHGRI PROTOCOLS | 75N92023D00009USAspending | $401,624 | Apr 30, 2026 | May 1, 2026 – Apr 30, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | DSC MANAGEMENT AND SUPPORT. APRIL 15, 2026 THROUGH NOVEMBER 30, 2027 N01DA-22-2253, TASK ORDER NO. 75N98026F00001 (TO 29) "COLLABORATIVE CARE FOR POLYSUBSTANCE USE IN PRIMARY CARE SETTINGS (CO-CARE)" | 75N95022D00017USAspending | $669,860 | Apr 17, 2026 | Apr 17, 2026 – Nov 30, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | EO14042 DEVELOPMENT, STATISTICAL DESIGN, MONITORING AND COORDINATION OF VISION CLINICAL TRIALS AND EPIDEMIOLOGY RESEARCH | — | $30,142,554 | Apr 17, 2026 | Nov 1, 2021 – Oct 31, 2026 |
| Prime | Department of Health and Human Services National Institutes of Health | RURAL EXPANSION OF MEDICATION TREATMENT FOR OPIOID USE DISORDER (CTN-0102). AUGUST 1, 2024 TO MARCH 31, 2026. N01DA-22-2253. TASK ORDER NO. 75N95024F00008 (TO24). | 75N95022D00017USAspending | $771,451 | Apr 1, 2026 | Aug 1, 2024 – May 31, 2026 |
| Prime | Department of Health and Human Services National Institutes of Health | FY23. TO 11 - CTN-0145: STANDARD VERSUS HIGH DOSE ED-INITIATED BUPRENORPHINE INDUCTION. POP: 8/28/23 - 8/27/24. | 75N95020D00012USAspending | $1,036,687 | Mar 23, 2026 | Aug 28, 2023 – Aug 27, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | DSC6 GENERAL MANAGEMENT AND SUPPORT. MARCH 1, 2026 TO APRIL 30, 2026. N01DA-22-2253. TASK ORDER NO. 75N95026F00001 (TO27). (EO) 14271: DAP-NCAP-00000077 | 75N95022D00017USAspending | $344,996 | Feb 27, 2026 | Mar 1, 2026 – Apr 30, 2026 |
| Prime | Department of Health and Human Services National Institutes of Health | INTEGRATED CARE AND TREATMENT FOR SEVERE INFECTIOUS DISEASES AND SUBSTANCE USE DISORDERS (SUD) AMONG HOSPITALIZED PATIENTS (CTN-0121). 09/28/2022 - 02/07/2026. DSC6. 75N95022F00002 (TO2). | 75N95022D00017USAspending | $2,067,729 | Jan 27, 2026 | Sep 28, 2022 – Sep 30, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF THE NATIONAL MYELODYSPLASTIC SYNDROMES (MDS) NATURAL HISTORY STUDY, DATA COORDINATING CENTER (DCC), TASK ORDER 03, SEPTEMBER 1, 2016-FEBRUARY 28, 2018 | HHSN268201400002IUSAspending | $13,756,583 | Sep 2, 2025 | Aug 30, 2016 – Dec 31, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF PRODUCTION ASSISTANCE FOR CELLULAR THERAPIES (PACT) - COORDINATING CENTER (CC) | — | $4,756,253 | Aug 25, 2025 | Jul 1, 2016 – Jun 30, 2021 |
| Prime | Department of Health and Human Services National Institutes of Health | OFFICE-BASED METHADONE VS BUPRENORPHINE TO ADDRESS RETENTION IN MEDICATION FOR OPIOID USE DISORDER (MOUD)-A PRAGMATIC HYBRID EFFECTIVENESS/IMPLEMENTATION TRIAL (CTN-013). 09/28/2022 - 08/04/2025. DSC6. 75N95022F00003 (TO3). | 75N95022D00017USAspending | $1,861,518 | Jul 30, 2025 | Sep 28, 2022 – Jan 31, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | DSC MANAGEMENT AND SUPPORT. MARCH 1, 2025 TO FEBRUARY 28, 2026. N01DA-22-2253. TASK ORDER NO. 75N95025F00001 (TO25). | 75N95022D00017USAspending | $2,349,295 | Jul 29, 2025 | Mar 1, 2025 – Feb 28, 2026 |
| Prime | Department of Health and Human Services National Institutes of Health | TO4. CLINICAL COORDINATING CENTER FOR NIDA'S CLINICAL TRIALS NETWORK. CONTRACT TYPE: IDIQ TASK ORDER. POP: 8/15/24 - 8/14/29 | 75N95024D00037USAspending | $4,656,081 | Jul 14, 2025 | Jul 16, 2025 – Jul 15, 2026 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF EMMES NEIS-V | — | $35,391,880 | Jul 11, 2025 | Oct 26, 2016 – Oct 31, 2020 |
| Prime | Department of Health and Human Services National Institutes of Health | NIDA DATA, STATISTICS, AND CLINICAL TRIAL SUPPORT CENTER MANAGEMENT AND SUPPORT. 03/01/2020 - 02/28/2021. N01DA-19-2250. TASK ORDER 75N95020F00001 (TO12). | 75N95019D00013USAspending | $2,645,396 | Jun 26, 2025 | Mar 1, 2020 – Feb 28, 2021 |
| Prime | Department of Health and Human Services National Institutes of Health | INTEGRATING PHARMACY-BASED PREVENTION&TREATMENT OF OPIOID&OTHER SUBSTANCE USE DISORDERS: A SURVEY OF PHARMACISTS&STAKEHOLDERS. 9/1/2020-7/31/2022. N01DA-19-2250. TASK ORDER 75N95020F00005(TO16). | 75N95019D00013USAspending | $347,989 | Jun 26, 2025 | Sep 1, 2020 – Jul 31, 2023 |
| Prime | Department of Health and Human Services National Institutes of Health | TRANSCRANIAL MAGNETIC STIMULATION FOR THE TREATMENT OF METHAMPHETAMINE/COCAINE USE DISORDER (CTN-0108). 9/21/2020-7/17/2023. N01DA-19-2250. TASK ORDER 75N95020F00007 (TO18). | 75N95019D00013USAspending | $806,041 | Jun 26, 2025 | Sep 21, 2020 – Jul 17, 2023 |
| Prime | Department of Health and Human Services National Institutes of Health | PEER INTERVENTION TO LINK OVERDOSE SURVIVORS TO TREATMENT (CTN-0107). 9/1/2020-7/3/2023. N01DA-19-2250. TASK ORDER 75N95020F00006 (TO17). | 75N95019D00013USAspending | $799,161 | Jun 26, 2025 | Sep 1, 2020 – Sep 30, 2023 |
| Prime | Department of Health and Human Services National Institutes of Health | LOGISTICAL AND IT SUPPORT FOR THE NCI CENTRAL INSTITUTIONAL REVIEW BOARD (CIRB) | — | $37,255,012 | Jun 12, 2025 | Sep 1, 2019 – Aug 31, 2024 |
| Prime | Department of Health and Human Services National Institutes of Health | PHARMACIST-INTEGRATED MODEL OF MEDICATION TREATMENT FOR OPIOID USE DISORDER. 12/01/2023 - 03/31/2025. N01DA-22-2253. TASK ORDER NO. 75N95024F00001 (TO17). | 75N95022D00017USAspending | $374,923 | May 29, 2025 | Dec 1, 2023 – Oct 31, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | CRAFT. SEPTEMBER 15, 2023 - MARCH 31, 2025. N01DA-22-2253. TASK ORDER NO. 75N95023F00011 (TO15). | 75N95022D00017USAspending | $799,919 | Apr 28, 2025 | Sep 15, 2023 – Apr 28, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | SECONDARY ANALYSIS. SEPTEMBER 15, 2023 - SEPTEMBER 14, 2026. N01DA-22-2253. TASK ORDER NO. 75N95023F00012 (TO16) | 75N95022D00017USAspending | $754,669 | Apr 28, 2025 | Sep 15, 2023 – Apr 28, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | CLINICAL RESEARCH SUPPORT AND COLLABORATION FOR NHGRI PROTOCOLS | 75N92023D00009USAspending | $360,623 | Apr 16, 2025 | May 1, 2025 – Apr 30, 2026 |
| Prime | Department of Health and Human Services National Institutes of Health | CTN CLINICAL COORDINATING CENTER SUPPORT POP 08/14/20-08/13/21 | 75N95020D00012USAspending | $3,744,212 | Mar 20, 2025 | Aug 14, 2020 – Aug 13, 2021 |
| Prime | Department of Health and Human Services National Institutes of Health | CTN CLINICAL COORDINATING CENTER - HEAL STUDIES. POP: 8/14/20-2/13/21 | 75N95020D00012USAspending | $2,938,848 | Mar 20, 2025 | Aug 14, 2020 – Jun 15, 2021 |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Subcontracting experience
12 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Subcontractor | Department of Health and Human Services | IN SUPPORT OF THE NIAID DMID H5N1 VACCINE CLINICAL TRIAL, LEIDOS BIOMED IS TASKED WITH THE MANAGEMENT OVERSIGHT AND CONDUCT OF THE H5N1 VACCINE CLINICAL TRIAL AND SEEKS TO CONTRACT WITH AN ORGANIZATION WITH THE CAPABILITIES TO PROVIDE DATA MANAGEMENT AND STATISTICAL ANALYSIS SUPPORT TO THE H5N1 VACCINE TRIAL AS OUTLINED IN THIS STATEMENT OF WORK. THE DATA MANAGEMENT AND STATISTICAL ANALYSIS ORGANIZATION SHOULD HAVE EXPERIENCE WITH INVESTIGATION NEW DRUG (IND) TRIALS, HAVE ALL THE NECESSARY REGULATORY REPORTING EXPERIENCE (PREFERABLY INFECTIOUS DISEASE), AND USE A VALIDATED 21 CODE OF FEDERAL REGULATIONS (CFR) PART 11 COMPLIANT SYSTEMS. 23X079F3 MOD 03 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: MD Parent award description: NIAID DMID INFLUENZA VACCINE PROJECT (H5N1) - INFLUENZA VARIANT VIRUS VACCINES View parent award on USAspending | 75N91019D00024USAspending | $2,097,661 | Aug 3, 2026 | — – — |
| Subcontractor | Department of Health and Human Services | OP2 FUNDING F-NIAID-EDMSCS-1152025-01_MOD02 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541512 Parent award performance state: MD Parent award description: THE CONTRACTOR SHALL PROVIDE ADDITIONAL SCIENTIFIC, TECHNICAL, AND ADMINISTRATIVE SERVICES IN SUPPORT OF THE CIVICS STATISTICAL, DATA MANAGEMENT AND COORDINATION CENTER (SDMCC). SPECIFIC TASKS INCLUDE:-DATA MANAGEMENT AND ANALYSIS-STATISTICAL DESIGN View parent award on USAspending | HHSN316201200128WUSAspending | $697,144 | Apr 28, 2026 | — – — |
| Subcontractor | Department of Health and Human Services | THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE AND PROVIDE FUNDING FOR BASE PERIOD (CONTRACT YEAR 1), OPTION 2 TASKS F-NIAID-EDMSCS-1152025-01 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541512 Parent award performance state: MD Parent award description: THE CONTRACTOR SHALL PROVIDE ADDITIONAL SCIENTIFIC, TECHNICAL, AND ADMINISTRATIVE SERVICES IN SUPPORT OF THE CIVICS STATISTICAL, DATA MANAGEMENT AND COORDINATION CENTER (SDMCC). SPECIFIC TASKS INCLUDE:-DATA MANAGEMENT AND ANALYSIS-STATISTICAL DESIGN View parent award on USAspending | HHSN316201200128WUSAspending | $550,000 | Dec 31, 2025 | — – — |
| Subcontractor | Department of Health and Human Services | EXERCISE AND FUND OY6. F-NIAID-SDMCC-2732019-01 MOD 15 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541714 Parent award performance state: MD Parent award description: CIVICS STATISTICAL, DATA MANAGEMENT AND COORDINATION CENTER (SDMCC) View parent award on USAspending | — | $3,376,306 | Sep 30, 2025 | — – — |
| Subcontractor | Department of Health and Human Services | EMMES WILL CONDUCT THE STATISTICAL DESIGN AND ANALYSIS, CLINICAL DATA MANAGEMENT, CLINICAL EDC SYSTEM TRAINING, AND
SMC/DSMB REPORT GENERATION FOR THE CIVICS PROGRAM, LEVERAGING TOOLS AND METHODS DEVELOPED BY THE SDMCC TO ACHIEVE
EFFICIENCIES AND ECONOMIES OF SCALE FOR THE EDMSCS. F-NIAID-EDMSCS-1152025-01 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541512 Parent award performance state: MD Parent award description: THE CONTRACTOR SHALL PROVIDE ADDITIONAL SCIENTIFIC, TECHNICAL, AND ADMINISTRATIVE SERVICES IN SUPPORT OF THE CIVICS STATISTICAL, DATA MANAGEMENT AND COORDINATION CENTER (SDMCC). SPECIFIC TASKS INCLUDE:-DATA MANAGEMENT AND ANALYSIS-STATISTICAL DESIGN View parent award on USAspending | HHSN316201200128WUSAspending | $961,638 | Apr 28, 2025 | — – — |
| Subcontractor | Department of Health and Human Services | C104 BDM STATEMENT OF WORK (MARBURG) A12548 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 541714 Parent award performance state: NY Parent award description: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACCINES ARE BASED ON RECOMBINANT EXPRESSION OF FILOVIRUS GLYCOPROTEINS IN View parent award on USAspending | — | $888,257 | Apr 9, 2025 | — – — |
| Subcontractor | Department of Health and Human Services | C109 BDM STATEMENT OF WORK (SUDV) A12549 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 541714 Parent award performance state: NY Parent award description: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACCINES ARE BASED ON RECOMBINANT EXPRESSION OF FILOVIRUS GLYCOPROTEINS IN View parent award on USAspending | — | $883,937 | Apr 9, 2025 | — – — |
| Subcontractor | Department of Health and Human Services | EMMES CONDUCTS THE STATISTICAL DESIGN AND ANALYSIS, CLINICAL DATA MANAGEMENT, CLINICAL EDC SYSTEM TRAINING, AND SMC/DSMB REPORT GENERATION FOR THE CIVICS PROGRAM, LEVERAGING TOOLS AND METHODS DEVELOPED BY THE SDMCC TO ACHIEVE EFFICIENCIES AND ECONOMIES OF SCALE FOR THE EDMSCS. F-NIAID-EXDMSC-1592022-01 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541512 Parent award performance state: MD Parent award description: THE CONTRACTOR SHALL PROVIDE ADDITIONAL SCIENTIFIC, TECHNICAL, AND ADMINISTRATIVE SERVICES IN SUPPORT OF THE CIVICSSTATISTICAL, DATA MANAGEMENT AND COORDINATION CENTER (SDMCC).SPECIFIC TASKS INCLUDE:-DATA MANAGEMENT AND ANALYSIS-STATISTICAL DESIGN AN View parent award on USAspending | HHSN316201200128WUSAspending | $2,257,553 | Mar 28, 2025 | — – — |
| Subcontractor | Department of Health and Human Services | IN SUPPORT OF THE NIAID DMID H5N1 VACCINE CLINICAL TRIAL, LEIDOS BIOMED IS TASKED WITH THE MANAGEMENT OVERSIGHT AND CONDUCT OF THE H5N1 VACCINE CLINICAL TRIAL AND SEEKS TO CONTRACT WITH AN ORGANIZATION WITH THE CAPABILITIES TO PROVIDE DATA MANAGEMENT AND STATISTICAL ANALYSIS SUPPORT TO THE H5N1 VACCINE TRIAL AS OUTLINED IN THIS STATEMENT OF WORK. THE DATA MANAGEMENT AND STATISTICAL ANALYSIS ORGANIZATION SHOULD HAVE EXPERIENCE WITH INVESTIGATION NEW DRUG (IND) TRIALS, HAVE ALL THE NECESSARY REGULATORY REPORTING EXPERIENCE (PREFERABLY INFECTIOUS DISEASE), AND USE A VALIDATED 21 CODE OF FEDERAL REGULATIONS (CFR) PART 11 COMPLIANT SYSTEMS. 23X079F3 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: MD Parent award description: NIAID DMID INFLUENZA VACCINE PROJECT (H5N1) - INFLUENZA VARIANT VIRUS VACCINES View parent award on USAspending | 75N91019D00024USAspending | $1,972,186 | Dec 9, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | CONDUCT THE STATISTICAL DESIGN AND ANALYSIS, CLINICAL DATA MANAGEMENT, CLINICAL EDC SYSTEM TRAINING, AND SMC/DSMB REPORT GENERATION FOR THE CIVICS SDMCC, USING PROCESSES DESIGNED TO ACHIEVE EFFICIENCIES BETWEEN THESE FUNCTIONAL AREAS. F-NIAID-SDMCC-2732019-01 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541714 Parent award performance state: MD Parent award description: CIVICS STATISTICAL, DATA MANAGEMENT AND COORDINATION CENTER (SDMCC) View parent award on USAspending | — | $3,174,838 | Sep 30, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | SERVICES GDIT-41794 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541512 Parent award performance state: VA Parent award description: COMPUTER SOFTWARE APPLICATIONS AND PROGRAMMING SUPPORT FOR THE BIOMETRICS RESEARCH PROGRAM View parent award on USAspending | HHSN316201200023WUSAspending | $1,449,924 | Nov 20, 2023 | — – — |
| Subcontractor | Department of Health and Human Services | IN SUPPORT OF ITS PRIME CONTRACT WITH INDEX ANALYTICS, EMMES USES THE
EXISTINGMEDDRAÃƑ¢â€ŠÂ¬BASED ADVERSE EVENT DIAGNOSTICS (MAED) MAINTENANCE,
SUPPORT, AND ENHANCEMENT SERVICES TRAINING MATERIALS PROVIDED BY THE COR FOR
PRIME AGREEMENT AS GUIDES TO DRAFT, DEVELOP AND MODIFY NEW TRAINING MATERIALS.
ADDITIONALLY, EMMES IMPLEMENTS THE TRAINING DELIVERY STRUCTURE IN ACCORDANCE WITH
REVIEWER EXPECTATIONS AND NEEDS (COLLECTED THROUGH MEAD TRAINING SUPPORT
ACTIVITIES) AND AS INSTRUCTED BY THE COR AND/OR COR DESIGNEE. THIS STRUCTURE
PROVIDES A FLEXIBLE AND ACCESSIBLE LEARNING ENVIRONMENT FOR USERS AND AN EFFICIENT
DEVELOPMENT, DELIVERY AND REVISION PROCESS FOR THE TRAINING PROGRAM. IA-S-STARS3-02 TO 02-1041 Parent award context Parent award agency: Department of Health and Human Services · Food and Drug Administration Parent award NAICS: 541512 Parent award performance state: MD Parent award description: MEDDRA-BASED ADVERSE EVENT DIAGNOSTICS (MAED) MAINTENANCE, SUPPORT, AND ENHANCEMENT SERVICES View parent award on USAspending | 47QTCB21D0217USAspending | $77,280 | Sep 12, 2022 | — – — |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Agencies supported
- Department of Health and Human ServicesGov-sourced